Trials / Recruiting
RecruitingNCT05054985
Safety and Efficacy of a Multi-branched Thoracoabdominal Stent Graft System for Thoracoabdominal Aortic Aneurysm.
Guo's Renovisceral Artery Reconstruction-1: a Prospective, Multicenter, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of a Multi-branched Stent Graft System for Thoracoabdominal Aortic Aneurysm (GUARANTEE Study)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 73 (estimated)
- Sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the safety and efficacy of a multi-branched thoracoabdominal stent graft system for thoracoabdominal aortic aneurysm.
Detailed description
The study is mainly for patients with thoracoabdominal aortic aneurysms, and all subjects who signed the informed consent and passed the screening will be enrolled. Patients who meet all the inclusion criteria and don't meet the exclusion criteria will be implanted with multi-branched thoracoabdominal stent graft system. Patients will be followed up at discharge, 1 month, 6 months, 12 months after the implantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Multi-Branched Thoracoabdominal Stent Graft System | Patients who meet all the inclusion criteria and don't meet the exclusion criteria will be implanted with multi-branched thoracoabdominal stent graft system . |
Timeline
- Start date
- 2021-11-12
- Primary completion
- 2025-12-31
- Completion
- 2028-12-31
- First posted
- 2021-09-23
- Last updated
- 2025-06-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05054985. Inclusion in this directory is not an endorsement.